	债务利息支出		日
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Agios Pharmaceuticals	USD 1.18B	4.3B	2026-03
Alnylam Pharmaceuticals	USD 69.29M	60.05M	2026-03
BioCryst Pharmaceuticals	USD 14.14M	5.53M	2025-12
BioMarin Pharmaceutical	USD 14.96M	12.18M	2026-03
Esperion Therapeutics	USD 22.64M	585K	2025-12
Immunic	197K	222K	2025-12
Insmed	USD 20.6M	217K	2025-12
Ionis Pharmaceuticals	USD 17M	1000K	2026-03
Karyopharm Therapeutics	USD 12.62M	1.24M	2025-12
Kyowa Hakko Kirin	JPY 435M	94M	2025-12
MacroGenics	USD 3.34M	2.54M	2025-09
Moderna	USD 11.49B	36B	2026-03
Neurocrine Biosciences	USD 1.1M	0	2024-03
PTC Therapeutics	USD 50.58M	2.59B	2025-12
Puma Biotechnology	USD 3.37M	11K	2024-06
Regeneron Pharmaceuticals	USD 12.9M	700K	2026-03
Sarepta Therapeutics	USD 7.56M	2.33M	2025-09
Ultragenyx Pharmaceutical	USD 19M	4.85M	2025-12
Vertex Pharmaceuticals	USD 3.3M	0	2025-12
Xoma	USD 3.4M	150K	2024-06